Confounding the paradigm: peculiarities of amyloid fibril nucleation

J Am Chem Soc. 2013 Jan 30;135(4):1531-9. doi: 10.1021/ja311228d. Epub 2013 Jan 22.

Abstract

Fibrils of amyloid proteins are currently of great interest because of their involvement in various amyloid-related diseases and nanotechnological products. In a recent kinetic Monte Carlo simulation study (Cabriolu, R.; Kashchiev, D.; Auer, S. J. Chem. Phys.2012, 137, 204903), we found that our simulation data for the rate of amyloid fibril nucleation occurring by direct polymerization of monomeric protein could not be described adequately by nucleation theory. It turned out that the process occurred in a peculiar way, thus confounding the nucleation paradigm and demanding a new theoretical treatment. In the present study, we reconsider the theoretical approach to nucleation of amyloid fibrils and derive new expressions for the stationary rate of the process. As these expressions provide a remarkably good description of the simulation data, by using them we propose a theoretical dependence of the amyloid-β(40) fibril nucleation rate on the concentration of monomeric protein in the solution. This dependence reveals the existence of a threshold concentration below which the fibril nucleation in small enough solution volumes is practically arrested, and above which the process occurs vigorously, because then each monomeric protein in the solution acts as fibril nucleus. The presented expressions for the threshold concentration and for the dependence of the fibril nucleation rate on the concentration of monomeric protein can be a valuable guide in designing new therapeutic and/or technological strategies for prevention or stimulation of amyloid fibril formation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / chemical synthesis*
  • Amyloid beta-Peptides / chemistry
  • Molecular Dynamics Simulation
  • Peptide Fragments / chemical synthesis*
  • Peptide Fragments / chemistry
  • Polymerization

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (1-40)